High Fitness Level Lowers Risk for Cardiovascular Death From High Blood Pressure

THURSDAY, April 13, 2023 (HealthDay News) -- High fitness levels attenuate, but do not eliminate, the increased risk for cardiovascular mortality in men with high blood pressure, according to a research letter published online March 23 in the European Journal of Preventive Cardiology.
Jari A. Laukkanen, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues used data from the Kuopio Ischemic Heart Disease study (2,682 men; ages, 42 to 61 years) to prospectively evaluate the relationship among systolic blood pressure, cardiorespiratory fitness (CRF), and cardiovascular disease-related mortality.
The researchers found that during a median 28.5 years of follow-up, for blood pressure alone, high blood pressure was associated with an increased risk for cardiovascular mortality (hazard ratio [HR], 1.39). For fitness alone, a low versus high level of fitness was associated with an elevated likelihood of cardiovascular death (HR, 1.74). However, men with high blood pressure and low fitness had more than a doubled risk for cardiovascular death versus participants with normal blood pressure and high fitness (HR, 2.35). Compared with men with normal blood pressure and high fitness, elevated cardiovascular risk remained but was diminished in men with high blood pressure and high fitness levels (HR, 1.55).
"These findings add to the emerging evidence that achieving and maintaining the highest level of CRF during adulthood is important for lowering the risk of chronic disease outcomes as well as death, and the most effective way of doing this is through regular and increased physical activity or exercise training," the authors write.
Related Posts
CDC Panel Urges Seniors to Get New, More Potent Flu Shot This Fall
THURSDAY, June 23, 2022 (HealthDay News) -- A U.S. Centers for Disease Control...
Twelve Symptoms Contribute to Postacute Sequelae of SARS-CoV-2
FRIDAY, June 2, 2023 (HealthDay News) -- A group of symptoms has been identified...
Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
THURSDAY, March 2, 2023 (HealthDay News) -- Glucagon-like peptide-1 receptor...
New ALS Drug Approved in Canada While Still Under FDA Review
MONDAY, June 13, 2022 (HealthDay News) -- An experimental drug for amyotrophic...
